Silver Oak Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,153
Closed -$279K 817
2025
Q3
$279K Buy
4,153
+54
+1% +$4.27K 0.02% 604
2025
Q2
$358K Sell
4,099
-2,631
-39% -$206K 0.03% 490
2025
Q1
$456K Buy
+6,730
New +$549K 0.04% 394
2024
Q3
Sell
-2,594
Closed -$294K 550
2024
Q2
$294K Buy
2,594
+76
+3% +$9.61K 0.04% 293
2024
Q1
$349K Buy
2,518
+839
+50% +$105K 0.05% 277
2023
Q4
$208K Buy
+1,679
New +$172K 0.03% 457
2023
Q1
Sell
-1,795
Closed -$203K 400
2022
Q4
$203K Buy
+1,795
New +$197K 0.04% 283

Other funds holding DXCM

Silver Oak Securities's DXCM Position: Q4 2025 in Review

Silver Oak Securities sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,153 shares — an estimated $279K sold.

Silver Oak Securities first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $456K in Q1 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Silver Oak Securities reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Silver Oak Securities sold 4,153 DexCom shares in Q4 2025, an estimated $279K.
  • Silver Oak Securities first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • Silver Oak Securities's DexCom position peaked at $456K in Q1 2025.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Silver Oak Securities's 13F filing for Q4 2025, filed 15 Jan 2026.